Duquesne's Druckenmiller Dumps Nvidia and Palantir, Piles into Teva Pharmaceutical Industries Ahead of 2026
ByAinvest
Thursday, Dec 25, 2025 1:59 pm ET1min read
NVDA--
PLTR--
TEVA--
Billionaire Stanley Druckenmiller sold his fund's stakes in Nvidia and Palantir, two AI darlings, and instead invested in Teva Pharmaceutical Industries, one of Wall Street's hottest drug stocks, for five consecutive quarters. Druckenmiller's decision to exit Nvidia and Palantir ahead of 2026 may not be solely due to profit-taking, as the stocks have experienced significant growth since the beginning of 2023. The shift in Druckenmiller's investment strategy highlights the importance of staying vigilant in the rapidly evolving tech landscape.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet